1. Izinhlamvu: Impushana emhlophe noma ecishe ibe mhlophe, ene-hygroscopic kakhulu.
2. Umthombo: I-porcine intestine mucosa.
3. Inqubo: I-Heparin sodium ikhishwa ku-mucosa yamathumbu e-porcine enempilo.
4. Izinkomba kanye nokusetshenziswa: Lo mkhiqizo usetshenziselwa ikakhulukazi ukuvimbela isifo se-thromboembolic, ikakhulukazi esilungele isidingo se-anticoagulant ngokushesha, njengalokhu: 1. I-acute noma engapheli ye-venous thrombosis noma akukho ukugeleza kwegazi okuphawulekayo ushintsho olunamandla lwe-pulmonary embolism(PE).Heparin ingamisa ukunwetshwa kwe-embolus ukwenza isikhathi se-thrombolysis ezenzakalelayo yomzimba.2. Ukuvimbela nokwelashwa kwe-Atrial fibrillation nge-embolism.3. Ukwelashwa kwe-diffuse intravascular coagulation (DIC) yokuqala.4. Ukuvimbela nokwelashwa kwe-peripheral arterial thrombosis noma i-myocardial infarction.5. Enye i-in vitro anticoagulation: njengokuhlinzwa kwenhliziyo nemithambo yegazi, i-in vitro circulation, i-hemodialysis, i-angiography, nayo ingasetshenziselwa ukumpontshelwa noma ukulungiselela isifanekiso segazi, okwamanje izinkomba eziyinhloko zokusetshenziswa kwe-heparin i-deep vein thrombosis(DVT), i-PE kanye ne-thrombosis. ezigulini ezisengozini enkulu.
·Uphumelele i-Chinese GMP
·Iminyaka engama-27 yomlando we-enzyme yebhayoloji ye-R&D
·Izinto ezingavuthiwe ziyalandeleka
·Thobela i-USP,EPnezinga lekhasimende
·Thumela emazweni nasezifundeni ezingaphezu kuka-30
·Inekhono lokuphatha uhlelo lwekhwalithi njenge-US FDA, Japan PMDA, South Korea MFDS, njll.
Izinto Zokuhlola | Ukucaciswa Kwenkampani | ||
EP | USP | ||
Izinhlamvu | Impushana emhlophe noma ecishe ibe mhlophe, ene-hygroscopic kakhulu | ||
Ukuhlonza | I-Thrombotest: Iyavumelana | Ubunikazi beChromatographic: Kuyavumelana | |
1I-H NMR Spectrum: Iyavumelana | 1I-H NMR Spectrum: Iyavumelana | ||
I-Liquid Chromatography: Iyavumelana | Isisindo-isilinganiso samangqamuzana isisindo: 15000 ~ 19000 | ||
I-Sodium: Iyavumelana | I-Sodium: Iyavumelana | ||
I-Anti-factor Xa ukuya ku-anti-factor IIa isilinganiso:0.9~1.1 | I-Anti-factor Xa ukuya ku-anti-factor IIa isilinganiso:0.9~1.1 | ||
Izivivinyo | Ukucaca nombala | Ukucaca: Kucacile, Umbala: ngo-5 noma ngaphezulu | ———— |
I-nitrogen | 1.5~2.5%(into eyomile) | 1.3~2.5%(into eyomile) | |
Ukungcola kwe-Nucleotidic | A260≤ 0.15(4mg/ml) | ≤ 0.1(w/w) | |
Izinto ezihlobene | Kuyavumelana | ———— | |
Umkhawulo wegalactosamine ku-hexosamine isiyonke | ———— | ≤ 1.0% | |
I-Oversulfate chondroitin sulfate | ———— | Kuyavumelana | |
pH | 5.5~8.0(1%) | 5.5~7.5(1%) | |
Ukulahlekelwa ekomisweni | ≤ 8.0%(60℃ Yomisa kuVacuum, 3h) | ≤ 5.0%(60℃ Yomisa kuVacuum, 3h) | |
Izinsalela ekushiseni | ———— | 28.0%~41.0% | |
I-endotoxin yebhaktheriya | ≤ 0.01 IU/Iyunithi Yamazwe Ngamazwe Ye-Heparin | ≤ 0.03 USP U/Iyunithi Yamazwe Ngamazwe Ye-Heparin | |
Insimbi enzima | ≤ 30ppm | ≤ 30ppm | |
Isodium | 10.5~13.5%(into eyomile) | ———— | |
Amaprotheni | ≤ 0.5%(into eyomile) | ≤ 0.1%(Isilinganiso sesisindo) | |
Umsebenzi | ≥ 180 IU/mg(into eyomile) | ≥ 180 USP U/mg(into eyomile) | |
Ukungcola Kwe-Microbial | I-TAMC | ≤ 1000cfu/g | ≤ 1000cfu/g |
I-TYMC | ≤ 100cfu/g | ≤ 100cfu/g | |
E.coli | Kuyavumelana | Kuyavumelana | |
I-Staphylococcus aureus | Kuyavumelana | Kuyavumelana | |
I-Salmonella | Kuyavumelana | Kuyavumelana |